The effect of inhibitors directed against two different molecular targets, i.e., protein kinase CK2 and TS, used alone or in combinations, was studied on two different breast cancer cell lines, MCF-7 and MDA-MB-231. Here, CSNK2A1 is linked to breast carcinoma.